Conn's Syndrome

Conn's Syndrome(来自ICD-11)

别称:

Hyperaldosteronism

Cushing Syndrome

Primary Hyperaldosteronism

Primary Aldosteronism

Hypercortisolism

Cushing's Syndrome

Cushing Disease

Conn Syndrome

Pituitary Corticotroph Micro-Adenoma

Pituitary-Dependent Cushing Syndrome

Corticotroph Pituitary Adenoma

Pituitary Acth Hypersecretion

Hyperadrenocorticism

Ectopic Acth - [adrenocorticotropic Hormone] Secretion Causing Cushing Syndrome

Primary Aldosteronism Due to Bilateral Adrenal Hyperplasia

Ectopic Acth - [adrenocorticotropic Hormone] Secretion

Cushing Syndrome Secondary to Ectopic Acth-Secretion

Primary Aldosteronism Due to Adrenal Hyperplasia

Pituitary-Dependant Hypercortisolism Disorder

Hypercortisolism Due to Nonpituitary Tumour

Pituitary-Dependant Cushing Syndrome

Pituitary-Dependant Hypercortisolism

Corticoadrenal Hypersecretion

Adrenal Gland Hyperfunction

Pituitary Cushing Syndrome

Adrenal Cushing's Syndrome

Adrenal Cortical Adenoma

Ectopic Cushing Syndrome

Idiopathic Aldosteronism

Cortisol Hypersecretion

Acth Syndrome, Ectopic

Aldosteronism Primary

Cushing Syndrome Nos

Cushing's Disease

Aldosteronism

加入收藏

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Conn's Syndrome, also known as hyperaldosteronism, is related to ectopic cushing syndrome and pigmented nodular adrenocortical disease, primary, 1, and has symptoms including cushingoid facies An important gene associated with Conn's Syndrome is USP8 (Ubiquitin Specific Peptidase 8), and among its related pathways/superpathways are Infectious disease and Metabolism. The drugs Bromocriptine and Liraglutide have been mentioned in the context of this disorder. Affiliated tissues include pituitary and adrenal gland, and related phenotypes are increased circulating cortisol level and paradoxical increased cortisol secretion on dexamethasone suppression test

查看原文参与反馈